Pathology News and Research

RSS

Pathology is the study and diagnosis of disease through examination of organs, tissues, bodily fluids, and whole bodies (autopsies). The term also encompasses the related scientific study of disease processes, called General pathology. Medical pathology is divided in two main branches, Anatomical pathology and Clinical pathology. Veterinary pathology is concerned with animal disease whereas Phytopathology is the study of plant diseases.

WVU program works towards preventing blindness in diabetic patients

When people think about the management of diabetes, A1C (hemoglobin) tests and foot exams usually come to mind. Often overlooked is the recommended retinal eye exam. This eye exam is crucial because many West Virginians with diabetes are at risk for blindness caused by diabetic retinopathy.

27 Jan 2020

The Mark Foundation Center for Advanced Genomics and Imaging established at JHU

The Mark Foundation for Cancer Research announced today the creation of The Mark Foundation Center for Advanced Genomics and Imaging at the Johns Hopkins University, which will receive initial funding of $5 million over 2 years.

27 Jan 2020

Study traces the molecular roots of hypertrophic cardiomyopathy

The heart's ability to beat normally over a lifetime is predicated on the synchronized work of proteins embedded in the cells of the heart muscle.

27 Jan 2020

A microdose lithium formulation could halt signs of Alzheimer's pathology

There remains a controversy in scientific circles today regarding the value of lithium therapy in treating Alzheimer's disease.

24 Jan 2020

UCI-led study reveals link between early life adversity and opioid addiction

Individuals with a history of early life adversity are disproportionately prone to opioid addiction. A new UCI-led study reveals why.

24 Jan 2020

Case Western researchers suggest potential Alzheimer's breakthrough

Researchers at the Case Western University School of Medicine say they have identified a previously unknown gene and associated protein which could potentially be suppressed to slow the advance of Alzheimer's disease.

21 Jan 2020

Patient-specific tumor organoids may one day be used to personalize cancer treatment

A patient-specific tumor organoid platform developed by Wake Forest Institute for Regenerative Medicine researchers and their cancer center colleagues could someday take the guessing game out of immunotherapy treatments.

21 Jan 2020

Prenatal alcohol and tobacco exposure linked to increased risk for SIDS

Children born to mothers who both drank and smoked beyond the first trimester of pregnancy have a 12-fold increased risk for Sudden Infant Death Syndrome (SIDS) compared to those unexposed or only exposed in the first trimester of pregnancy, according to a new study supported by the National Institutes of Health.

20 Jan 2020

Editor's Pick: Life Science Interviews from 2019

In this article, our editors look back at their favorite life science interviews from 2019.

17 Jan 2020

UT Southwestern study identifies new vulnerability in kidney tumors

A UT Southwestern researcher led a team that identified a new vulnerability in kidney tumors, the 10th most common cause of cancer death in men and women.

17 Jan 2020

New sensitive marker may enable early diagnosis, treatment of spotted fever rickettsioses

Rickettsiae are bacteria that cause severe, potentially lethal human infections, including Mediterranean spotted fever and Rocky Mountain spotted fever.

16 Jan 2020

MGH laboratory develops new technology to reduce fat

How cool is this: the Massachusetts General Hospital laboratory that invented cryolipolisis or "Coolsculpting," a popular non-surgical method for reducing fat under the skin, is developing a new form of the technology that can selectively reduce fat almost anywhere in the body using a safe, injectable ice solution or "slurry."

14 Jan 2020

How SpatialOMx is Delivering New Insights into Disease Research

An interview with Shannon Cornett Ph.D, discussing the use of MALDI-guided spatial molecular analysis for biomarker discovery.

From Bruker Daltonics 14 Jan 2020

Updated breast cancer guideline offers recommendations for handling cases with low ER expression

The updated guideline for estrogen and progesterone receptor (ER/PgR) testing in breast cancer, published jointly today by the College of American Pathologists and the American Society of Clinical Oncology, reaffirms much of the original guidance and has more specific recommendations for handling and reporting cases with low ER expression.

13 Jan 2020

Study uncovers new subtypes of advanced pancreatic cancer

Researchers at the Ontario Institute for Cancer Research and the University Health Network have discovered detailed new information about the subtypes of pancreatic cancer. A better understanding of the disease groups may lead to new treatment options and improved clinical outcomes for this lethal disease.

13 Jan 2020

Researchers identify new pathway as biological target for colon cancer

Researchers have found a way to help make chemotherapy more effective in treating colon cancer. They identified a new pathway (RICTOR/mTORC2) as a biological target for the disease.

13 Jan 2020

A class of antibiotics could be potential treatment for frontotemporal dementia

Researchers at the University of Kentucky's College of Medicine have found that a class of antibiotics called aminoglycosides could be a promising treatment for frontotemporal dementia.

10 Jan 2020

Study demonstrates accuracy of AI system in diagnosing prostate cancer

The Lancet Oncology has today published the results of a study demonstrating the accuracy of an artificial intelligence system in diagnosing prostate cancer in tissue samples.

10 Jan 2020

Common genetic defect in prostate cancer associated with worse prognosis

Like security screening to make sure nothing harmful makes its way into a crowded area, cells in the human body use checkpoints to control their growth and prevent harmful mutations from making their way into new cell populations and causing trouble.

9 Jan 2020

Nano-sized copper compounds together with immunotherapy can kill cancer cells

An interdisciplinary team of scientists from KU Leuven, the University of Bremen, the Leibniz Institute of Materials Engineering, and the University of Ioannina has succeeded in killing tumour cells in mice using nano-sized copper compounds together with immunotherapy. After the therapy, the cancer did not return.

9 Jan 2020